ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Standards Program
The Standards Committee is responsible for the development and maintenance of voluntary consensus standards that address the design, analysis, and operation of components, systems, and facilities related to the application of nuclear science and technology. Find out What’s New, check out the Standards Store, or Get Involved today!
Latest Magazine Issues
Nov 2025
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
December 2025
Nuclear Technology
Fusion Science and Technology
November 2025
Latest News
X-energy raises $700M in latest funding round
Advanced reactor developer X-energy has announced that it has closed an oversubscribed Series D financing round of approximately $700 million. The funding proceeds are expected to be used to help continue the expansion of its supply chain and the commercial pipeline for its Xe-100 advanced small modular reactor and TRISO-X fuel, according the company.
Ali E. Dabiri, William K. Hagan, Donald A. Swenson, Kenneth A. Krohn
Nuclear Technology | Volume 92 | Number 1 | October 1990 | Pages 127-133
Technical Paper | Development of Nuclear Gas Cleaning and Filtering Techniques / Radioisotopes and Isotope Separation | doi.org/10.13182/NT90-A34492
Articles are hosted by Taylor and Francis Online.
The feasibility of using a radio-frequency quadrupole (RFQ) accelerator to accelerate 3He++for use in positron emission tomography (PET) is shown. The 3He++ RFQ is extremely lightweight in comparison to a cyclotron, but can nevertheless produce all four radioisotopes of interest (18F, 13N, 15O, and 11C) in more than adequate quantities. Due to the neutron-poor nature of 3He++, the desired positron emitters can be produced from naturally abundant target isotopes. In addition, target reactions and collisions with the accelerating structure produce relatively small numbers of neutrons compared to proton and deuteron systems. This yields two economic advantages. Enriched 13C, 15N, and 18O target materials are not required. Also, the shielding requirements are reduced considerably, and there is no need for radiation shielding around the accelerator. This reduced shielding results in a factor of 8 reduction in total facility shielding weight compared to a proton/deuteron cyclotron facility. The order of magnitude reduction in facility weight, the virtual elimination of the accelerator weight, and the relative lack of residual induced activity gives rise to the possibility of a radiopharmaceutical production system that is less expensive than present systems and may ultimately be transportable. Such a system could make PET imaging technology far more accessible geographically and financially than it is at present.